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ABSTRACT (200 words) 
Community pharmacy faces ongoing challenges to its economic and social standing.  A 
concern to legitimate professional status explains the attraction of public health. Interventions 
currently advocated by UK State-sponsored healthcare seek to reconcile the autonomous 
‘entrepreneurial’ patient with market-driven solutions.  Engaging critically with recent 
Foucauldian sociological work on pharmacy as a conduit for disciplinary power, we explore 
how professional ambiguity is exploited to ‘manage’ the subjectivities of community 
pharmacists. Locating our discussion in the observed empirical realities of pharmacy practice, 
(the inclusion of alcohol and other ‘healthy living’ advice in the Medicines Use Review) we 
connect unresolved historical debates in community pharmacy with current ongoing 
(neoliberal) changes in policy and pharmacy business practices, drawing attention to the poor 
evidence base underpinning healthy living activities in community pharmacy. Our findings 
show how community pharmacists struggle to provide meaningful advice, valued by patients. 
Instead of enhancing professional status, ‘add-on’ public health roles created the risk of 
offering little more than an essentialised enactment of consumerist healthcare.  Understanding 
how patients conceptualise drinking and ‘healthy-living’ in relation to their long-term health, 
using more open discussions, including the negotiation (rather than provision) of information, 
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could help community pharmacists challenge the current professional vulnerabilities they 
face. 
Key words: community pharmacy, patient-centred-care, public health, professional role, 
alcohol, qualitative research 
 
INTRODUCTION 
In the UK (and elsewhere) community pharmacy occupies an ambiguous professional 
position as it searches for a credible role within the changing context of modern healthcare 
(Martin and Waring, 2018). The struggle for professional standing is long-standing and much 
of the debate has been focused on pharmacy’s subordination to medicine (McDonald et al., 
2010, Cooper et al., 2009).  UK community pharmacy is currently sited in the fragmented 
internal market of a reorganising National Health Service (NHS) facing workforce challenges 
in primary care (NHS, 2019; Iacobucci, 2017).  Community pharmacists, as private 
contractors engaged by the NHS, provide local pharmaceutical services within a retail setting, 
in addition to a range of products for customers to purchase. Amidst concerns of its demise, 
and by aligning traditional claims to expert and altruistic practice with emerging discussions 
associated with patient choice, the profession has developed an interest in public health 
(Walker, 2000; Waring et al., 2016, Cooper, 2020). 
Taking on an extended role within the corporate and policy rationalities of healthcare 
reorganisation carries risk as well as opportunity. Drawing on recent Foucauldian analyses of 
the changing forms of power brought about by community pharmacists assuming an extended 
role, here we locate this risk empirically in the ‘healthy living’ aspect of The Medicines Use 
Review (MUR). The MUR, introduced by the 2005 NHS Community Pharmacy Contractual 
Framework (CPCF), offers a form of remunerated patient engagement, which since 2012 has 
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included ‘healthy-living advice’.  Pharmacists are expected to advise on alcohol, smoking, 
physical activity, nutrition, weight management and/or sexual health (PSNC and NHS 
Employers., 2012).  By focusing on this advice as negotiated in practice, rather than relative 
to an idealised professional role described in policy and supported by professional rhetoric, 
we examine how a governmentality that privatises risk finds expression in community 
pharmacy (Rose, 2009).  We specifically question the extent to which ‘the pharmacy gaze’ 
(Jamie, 2014) is being extended and whether pharmacists are assuming the responsibility for 




Navigating neoliberal health norms 
As the twentieth century ended, Governments became increasingly concerned with reducing 
dependency on State-sponsored welfare by promoting market-orientated solutions (Martin 
and Waring, 2018).  Community pharmacists, like other healthcare professions, accept 
responsibility for ensuring the normative operation of these concerns in exchange for 
maintaining professional standing (Waring et al., 2016, Dingwall, 2008).  In doing so, they 
navigate: growing deregulation of pharmaceutical sales; the commercial expediencies of 
increasingly large corporate-owned pharmacies; an increasing use of targets to which 
remuneration is tied; comparisons with medical professionals; and expectations to extend 
professional roles (Bush et al., 2009, Taylor and Harding, 2003). 
Many current public health interventions, by privileging individual empowerment at the 
expense of collective action and structural reform, reflect the ordering influence of neo-
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liberalism (Popay et al., 2010).  Preventative strategies, principally involving the provision of 
information and advice, are not only regarded as cost-effective, but encourage individual 
action and personal responsibility, independent of direct State intervention. Professions are 
called on to facilitate these expectations, help promote desirable subjectivities and introduce 
risk management (Rose, 2007). Recent Foucauldian inspired-work has explored the idea of 
‘inscriptive confessional practices’ in healthcare, whereby ‘pastoral’ activity might inspire 
patients to internalise values, as a form of governmentality in which obligation becomes 
associated with responsibility (Martin and Waring, 2018). The individual subject is thereby 
rendered ‘entrepreneurial’ (Brown, 2015) and following purposeful conversations 
administrated by professionals, risk is privatised through the exercise of ‘pastoral’ care 
(Waring et al., 2016; Foucault, 2007).  Taking on a more ‘pastoral’ role requires responding 
to broader transformative ideas about ‘the patient’, while operating within a changing 
mercantile environment, in which the demands of the ‘market’ generate tensions with 
altruistic practice (Waring et al., 2016). 
Beginning with Denzin and Mettlin’s (1968) paper on the ‘incomplete professionalization’ of 
pharmacy, sociological work has questioned the extent to which community pharmacy has 
been motivated by commercial rather than altruistic goals, particularly since it ceded control 
to the pharmaceutical industry of the social object (the drug) around which it is organised, 
while accepting payment from the State for performing certain activities (Martin and Waring, 
2018).  From compounding and transforming drugs into medicines, the pharmacist has 
become an agent through which medicinal drugs and devices are safely distributed and their 
purpose understood (Harding and Taylor, 1997).  Contracting to meet State agendas poses 
limitations on professional autonomy in an occupation sometimes seen as a ‘trade’ (Bush et 
al., 2009), in which patient interactions are short, instrumental, transactional and over-the-
counter.  Pharmacists conduct the required legal, clinical and accuracy checks on medicines 
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in the dispensary, leaving occasionally to provide information or respond to customer 
inquiries about medicines and health-related products.  Much patient contact is delegated to 
counter staff and interactions are often with proxies (friends and relatives collecting 
medicines) rather than the patient themselves (Cooper et al., 2009). 
 
Extending community pharmacy 
Calls to extend the role of community pharmacists, dating back to the Nuffield report (1986), 
have emphasised their relative availability and approachability rather than the depth or 
exclusivity of their knowledge.  The availability of pre-packed medicines without 
prescription in retail outlets other than pharmacies, has undermined the pharmacist’s 
customary role in dispensing medicines (Harding and Taylor, 1997).  Detailed information 
leaflets, the rise of the ‘expert patient’ and increased online availability of medicines (and 
medicines’ information) further reduce reliance on pharmacists’ expert knowledge and the 
physical pharmacy space (Cooper, 2020). 
Current enthusiasm for extending pharmacy services, including advice on ‘healthy-living’, is 
linked to a sense that the third largest healthcare profession (globally) is an ‘untapped’ 
resource able to contribute positively to community well-being (Murray, 2016, p3).  
Becoming a ‘hub enabling people to lead healthier lives’ creates possible futures in which 
community pharmacists become a recognised asset for improving public health (Department 
of Health, 2016 p1).  However, the ‘routines, relationships and rituals’ that construct 
everyday professional practice can generate challenges (Waring and Bishop, 2011 p664).  
The ongoing promotion of pharmacy services as available without appointments, unlike the 
‘over-burdened’ General Practitioner (GP), assumes the availability of pharmacists. This 
somewhat contradicts a professionalising strategy that encourages the public to view 
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pharmacist’s time as valuable.  Patients, for their part, perceive the core dispensing process as 
a retail exchange of prescription-form and drug (NICE, 2020). They rarely recognise the 
pharmacists’ role in supporting self-care (Elvey et al., 2013), considering the GP a more 
qualified source of information (Latif, 2017).  Further, the annual survey published by 
Chemist and Druggist in (2019) stated that 74 per cent of pharmacists identified as 
experiencing workplace stress, with little capacity to take on additional work. The 
preventative public health work pharmacists ‘are ready and willing to assume’ (PHE, 2016 
p3), also continues to be less resourced than dispensing and clinical health roles (Health 
Foundation and Kings Fund, 2019). 
Earlier attempts at the ‘reprofessionalization’ of community pharmacy included a basic role 
in ‘health promotion’, such as being contracted to display posters and leaflets (Bush et al., 
2009). Pharmacy’s focus on providing individual services and its restricted potential to 
engage with the structural and political causes of ill health at the population level have been 
identified as limitations in its approach to public health (Jesson and Bissell, 2006; Walker, 
2000). There have been few accompanying recommendations on how the profession might 
practically address this (Bush et al., 2009). The ‘positive pharmacy care law’ (Todd et al., 
2014), refers to the potential pharmacies have in reducing inequalities in ‘priority public 
health conditions’ given that pharmacy density is greater in areas of highest deprivation. This 
study considers only geographic proximity and not availability or accessibility of services.  
Arguably, pharmacy density in disadvantaged communities is not surprising given that poor 
health creates a market for medicines.  The potential pharmacy resource identified could also 
be seen as a reflection of pharmaceutical overtreatment (Godlee, 2019).  A recent review of 
reviews of community pharmacy-delivered public health interventions identified evidence of 
effects of some services (e.g. smoking cessation, syringe/needle exchange and inoculation) 
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but little evidence on health inequalities (Thomson et al., 2019).  Evidence remains lacking on 
whether increased leaflet uptake has any impact on health behaviour change (NICE, 2020).     
A growing number of pharmacies adopted the Healthy Living Pharmacies (HLP) framework 
before it was made compulsory in the latest CPCF (DHSC, 2019). The new contract requires 
HLPs to create teams that are aware of local health issues and consistently demonstrate they 
are promoting public health (DHSC, 2019).  In 2019, over 80% of community pharmacies in 
England declared themselves an HLP (level 1) (PSNC, 2020a).  This is despite a lack of 
evidence on effectiveness in improving health outcomes (Nazar et al., 2019). There is some 
evidence that pharmacists have considered levels of HLP remuneration insufficient to divert 
their focus from dispensing (Langley et al., 2014). This explains why such activities are 
mostly delegated to non-pharmacist staff (Eades et al., 2011). When considered alongside 
community pharmacists’ formal lack of public health knowledge (Bush et al., 2009), it is not 
difficult to appreciate the challenges of establishing a ‘hub’ facilitating healthy-living 
(Anderson et al., 2003). 
Contract and trade considerations 
Payments associated with contractual activity carry the risk that community pharmacy 
becomes defined by policy rather than professional practice (Martin and Waring, 2018). 
Traditionally, the majority of community pharmacies operated as independent businesses, run 
by owner-managers.  There is now increasing ownership by multiple contractors.  The 2005 
CPCF, by opening the way for supermarket, primary care and distance-selling pharmacies, 
resulted in larger businesses providing dispensing services (Hann et al., 2017). The rise of 
large-scale corporate pharmacies and the demands of efficiency, routinisation, predictability 
and standardisation, referred to as ‘McDonaldization’ further constrains professional 
autonomy (Ritzer and Elizabeth, 2000;  Harding and Taylor 2000; Bush et al., 2009).  Expert 
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advice is reduced to formulaic, (a)contextual application with little opportunity for 
professional discretion (Lipsky, 2010). 
Consequently, the relative commercial advantages of taking on additional commissioned 
services to compensate for reductions in NHS funding (DH, 2016), have to be weighed 
against providing products (trade) and private services (fees) that encourage the marketisation 
and commodification of healthcare (Kickbusch and Payne, 2003).  These include screening 
and monitoring, in addition to cosmetic products and services (Finch, 2018).  Pharmaceutical 
companies are also increasingly moving into the ‘wellness’ market, with over-the-counter and 
prescription dietary supplements, preventive medicine and ‘lifestyle’ drugs to treat life-course 
‘conditions’ such as baldness and impotence. Examples of State-paid contract services 
include remuneration for displaying health promotion materials; providing influenza 
vaccination; and offering general (rather than specialist) health advice via medicines’ 
management (Mackridge et al., 2017).  All of which provide little opportunity to demonstrate 
professional competence (Hann et al., 2017). 
STUDYING ROUTINE PRACTICE 
Our analysis explores how community pharmacists negotiate these challenges, while 
attempting to enhance their professional standing, by drawing on qualitative material 
collected as part of a five-year research programme. The CHAMP-1 programme investigates 
the potential contribution of pharmacists to optimise discussion of alcohol during routine 
practice. It is informed by prior work on brief interventions, which found no benefit to 
patients in community pharmacies (Dhital et al., 2015). Here we look at the wider contexts of 
the public health work in which alcohol is situated.   By focusing on the ‘healthy-living 
advice’ aspect of the MUR, we offer a case study of where public health advice is negotiated 
between pharmacist and ‘patient’.  MUR is designed to support patient adherence to 
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treatment and resolve medicine-related problems (Latif, 2017).  Since 2007, over four million 
MUR consultations have been conducted (Stewart et al., 2019).  
Exploratory and feasibility observations were undertaken in ten community pharmacies in the 
North of England, featuring 14 community pharmacists, as part development of an 
intervention (Madden et al., 2020b). This involved shadowing pharmacists, observing their 
routine practice (including MUR consultations) and carrying out informal interviews as they 
conducted their work.  Two researchers undertook 63 hours of observations and initiated 
focused conversations with pharmacists.  Observations focused on understanding the working 
environment, recruitment of patients and conduct of reviews.  The aims included identifying 
opportunities for person-centred discussion, including alcohol. Some early observation 
findings have been reported elsewhere (Morris et al., 2019). In addition, semi-structured 
interviews were conducted with seven of the pharmacists who took part in a later feasibility 
study, which informed the development of a pilot RCT. 
Semi-structured interviews were also conducted with 25 people (16 men and nine women, 
mean age 64), who drank alcohol and took multiple medicines.  These interviews explored 
whether they were open to the idea of talking with a pharmacist about alcohol as part of a 
medicines’ review (Madden et al., 2020a).  Interviewees were recruited from seven of the 
community pharmacies where observations had taken place.  Interviews, conducted in 
participant’s own homes and digitally recorded, used a topic guide, which comprised open-
ended prompt questions on the use of medicines and alcohol; use of the pharmacy; experience 
of medicines reviews; and thoughts on talking about alcohol as part of a MUR. 
Transcribed interviews and contemporaneous field-notes, narratively expanded by the 
researcher shortly after leaving the pharmacy, form the basis of our analysis. Some a-priori 
codes were established from the interview schedule and observation template, but detailed 
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coding was developed through iterative retrospective analysis.  The broader team checked the 
stability and reproducibility of coding.  Analytical materials are understood as co-constructed 
through interactions between the participants and the researchers, whose interest in alcohol 
was transparent. These were organised using a modified framework method (Gale et al., 
2013) which supported a constructionist thematic analysis (Braun and Clarke, 2006).   
Analysis of interaction is derived from observer field notes.  The studies received UK Health 
Research Authority ethics approval (REC reference 17/YH/0406).  Interview participants 
were given verbal and written information explaining the study aims and their involvement. 
Written consent was obtained and interviewees given assurances about confidentiality.  
Empirical analysis for this paper focused on pharmacists’ discussion of healthy-living advice, 
within the context of competing demands, as they attempt to fulfil a broader clinical and 
public health role, consistent with protecting and enhancing their sense of professional 
standing.  This included theoretically exploring the potential for ‘pastoral care’ to shape 
patients’ ‘self-regulating subjectivities’ (Waring et al., 2016 p123). 
 
FINDINGS 
Business as usual? In search of time and space, when managing competing demands 
Community pharmacies were busy environments.  Many pharmacists (although not those 
working in independent pharmacies) reported pressure to achieve a target of 400 MURs per 
year (the current cap for remuneration): 
Everything is a target, everything, because the Government’s taking money from 
pharmacy and the only way to recoup…to get the money back is to do more services 
that increase the footfall in the pharmacy because if…there's no profit there's no 
business…the target is the patient…at the end of the day...you do not think MUR’s 
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appropriate for that patient but they say to you…just do it anyway (INV-I-PH-05: 
interview-intervention arm-pharmacist-number) 
This pharmacist stated that by interpreting the cap as a ‘target’, MURs became an 
instrumental means to generate contractual income rather than deliver patient benefit. Targets 
were visible in some pharmacies on wall-posters, offering staff incentives: 
I notice the ‘biggest recruiter prize’ on the wall in the dispensary for MURs. They get 
a free day off for winning (OBS-005: observation number). 
Some pharmacists claimed that unnecessary MURs were being conducted in other 
pharmacies (but not their own), ‘simply to get pay’ (OBS-005), gaming the system.  As found 
in previous studies, support staff identified eligible patients during routine dispensing (Latif 
et al., 2013).  People waiting for prescriptions were asked if they had time for a ‘quick chat’ 
with the pharmacist.  Most agreed that ‘the difficult bit is getting them in there’ (gestures at 
the consultation room) (OBS-002), without alienating the ‘customer’: 
The way the assistant asks is very informal, not mentioning the…term, 
MUR…’You’re actually due a little chat with [name of pharmacist], just to check 
you’re OK, it will take only five minutes if that’s OK’ [Another member of support 
staff says] ‘They’ve got no time, have they? Always in a rush’ (OBS-005). 
Those recruiting to MURs had strategies to minimise the chances of people saying ‘no’.  
However, little explanation of context was provided and the potential value to the patient 
downplayed. 
 
Most receiving a MUR appeared happy with the ‘chat’, but unclear about its purpose, with 
poor recall of its content (see Latif et al., 2018).  For those with health-related queries, most 
expressed a preference to talk to their GP, who they believed better qualified to offer advice: 
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I went to a pharmacy, well… just the pharmacy department in a big department store 
thing, and asked if they had any creams or something like that, sort of steroid type 
cream. I was prescribed something but it didn't do any good.  So I then got a proper 
appointment [with the GP] and got the proper stuff (INV-Pat-22: Interview patient 
number). 
A few reported feeling more comfortable talking about their health with a pharmacist.  
Pharmacists were seen to have more time, but also less opportunity to reinforce decisions: 
I find it better with the pharmacist actually… because he seems to have more time for 
you…there’s been a few times when I’ve wanted to talk to the doctor and…he gives 
me the impression that he hasn’t got time for me…I think you get scared that [the GP] 
he’s just going to stop your medication if you tell him the truth about anything…You 
don’t really say anything with the GP because you know what his answer is going to 
be (INV-Pat-10).  
Some knew their pharmacist but others regarded it as an impersonal service, supplemental to 
‘proper’ advice from the GP. 
 
The core dispensing function of community pharmacists (and associated commercial 
priorities) had to be juggled alongside the need to offer a professionally valued service.  The 
material context of the pharmacy reinforced this tension, highlighting competing pressures on 
the use of time and space (MURs have to be conducted in a consultation room).  Pharmacists 
who did not have another pharmacist to ‘cover’ felt ‘under pressure’ to return to the 




Because in the shop people are waiting and they want you to hurry up because at the 
end of the day it's more targets as well…MURs should take about…ten to 15 minutes.  
What if you're taking about 20/25 minutes?  The staff [say], oh, come out, do this, do 
that (INV-I-Ph5). 
Without cover or with a competing demand on the room, pharmacists’ experienced frequent 
interruptions: 
At this point [pharmacy dispenser] pops his head through the sliding door and says, 
‘can I use the room for a C-card?’ [free condoms for young people]. We begin to 
move our things…Less than a minute later [another member of pharmacy staff] pokes 
her head through sliding door and asks the pharmacist: ‘Can I bring in an MUR?’ We 
go out…and I walk to till area where I ask, ‘is C-card happening in the consultation 
room or MUR?’ She says, ‘we are pushing for MURs today’ so the C-card will be at 
the desk over there, she points to where [pharmacy dispenser] is already doing it 
(OBS-006). 
Interruptions could give the impression that the consultation was not important, making it 
difficult to establish rapport, while offering a further reminder of the contrast between the 
standing of GPs and pharmacists.   
Some pharmacists spoke about the particular difficulties of time management and choosing 
what to prioritise, seeking to avoid a backlog in dispensing. Services competing for 
consultation space with MURs included a range of private and NHS healthcare services: 
vaccinations; sexual health clinics; morning after contraception; HIV testing; and a remote 
independent prescriber service via webcam. NHS or local authority commissioned services 
vary regionally and in our sites, included some smoking cessation (also offered privately); 
14 
 
blood pressure checks; minor ailment service; influenza vaccination and supervised 
methadone services. 
Interruptions reflect the realities of routine practice.  One pharmacist explained that his 
pharmacy was next door to a medical practice which had received a Care Quality 
Commission rating of ‘inadequate’.  His workload included people who could not get a GP 
appointment.  The ‘cover pharmacist’ expected on the day of the observation had not arrived.  
That afternoon the pharmacist covered dispensing, fielded numerous telephone calls 
(including supply chain issues), advised customers at the counter, did two face-to-face 
MURs, a (telephone) new-medicines review and saw three people in the consultation room 
with potentially serious clinical issues.  The consultation room was also occupied for some 
time by a pharmacy technician and a young man refusing to take his medications: 
She comes out and says he is now saying he wants to die. The pharmacist asks if she 
thinks he is suicidal, does she want him to ring 111? They agree calling an ambulance 
may be provocative if he does not want to go to hospital. He got ‘fobbed off’ by a 
doctor yesterday. He has a rash. The technician agrees to go back in to advise him 
about the rash and see if they can arrange some cream. The pharmacist phones 111 
but is on hold on the telephone for some time, then gives up. The pharmacist explains 
that the technician will spend some time listening to him and showing that she cares 
about what he says to see if that makes a difference. This keeps the room occupied. 
After some time he calms down. They come out and she gives him some cream (OBS 
008). 
Ticking the healthy-living advice box 
Observed MUR consultations were short (mean length, 10 minutes) and although the 
guidance recommends using open, exploratory questions, most comprised closed questions to 
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check if patients were taking medications, knew what they were taking them for; and identify 
any problems.  Questions about healthy-living featured at the end of the consultation.  A 
‘dataset form’ is completed during or following each MUR (by ‘ticking a box’) to indicate 
the advice given.  Policy (and service specifications) describe the MUR as an individually 
tailored patient-centred service (Latif et al., 2018).  Pharmacists, however, tended to use the 
prescription-list to structure the consultation, conflating ‘understanding’ with 
‘reinforcement’.  The dataset form encouraged this: 
As a result of the MUR the pharmacist believes there will be an improvement in the 
patient’s adherence to the medicine as a result of the following (more than one may 
apply): 
a) better understanding/reinforcement of why they are using the medicine/what it is 
for; 
b) better understanding/reinforcement of when/how to take the medicines; 
c) better understanding/reinforcement of side effects and how to manage them; 
d) better understanding/reinforcement of the condition being treated (PSNC, 2020b)  
Towards the bottom of the form were a series of boxes to identify the healthy living advice 
provided (more than one might apply): Diet & nutrition; Smoking; Physical activity; Alcohol; 
Sexual health; Weight management; Other. There was also a box ‘Healthy living advice not 
applicable’ (PSNC, 2020b).   
Pharmacists perceived medicines safety and adherence as being the core purpose of the MUR 
(see Salter, 2010).  They were confident in questioning patients about this, but ill-at-ease 
when probing ‘healthy-living’: 




Pharmacist: Fruit and veg? 
P: I have full dinners. 
Pharmacist: Plenty of fresh veg with dinners? 
P: Oh yes, but not fruit.  
Pharmacist: Not keen?  
P: Wouldn’t go and buy it.  
Pharmacist: That’s fine.  
Pharmacist: Physical activity? 
P: I do plenty of walking.  
Pharmacist: 20 minutes? Research suggests 20 minutes of walking a day is good for 
your heart. 
P: I’m always rushing about. Can’t sit still.  
Pharmacist: Alcohol? 
P: Tot of brandy 
Pharmacist: At night before bed? 
P: Yeah, brandy and coke  




When asked why he left all the healthy-living questions to the end, when it may have been 
more pertinent to raise them within the context of the health issues for which medicines were 
being taken, the pharmacist replied: 
Because that’s what we’ve always done.  We focus on the medicines first because we 
are pharmacists (OBS-005). 
Questions about ‘healthy-living’ gathered information with minimal exploration.  Sometimes 
pharmacists offered ‘common-sense’ injunctions to exercise, eat well, drink moderately or 
provided leaflets (and information) detailing their services, such as smoking cessation.  Some 
pharmacists avoided the questions altogether, while others rushed through them, focusing on 
one particular aspect and commenting more informally on their own behaviour: 
Pharmacist: Ok, so do you smoke? 
Person: No. 
Pharmacist: Do you drink? 
P: Yeah 
Pharmacist: How often? 
P: Once per week on a Saturday, the rest of the days are in the gym.  
Pharmacist: Oh what do you do in the gym? 
P: I do it day by day, cardio then weights. It’s Monday-Friday.  
Pharmacist: I just joined a gym and I find it very hard.  
P: I used to do sports.  Boxing, football but stopped around 50. I still play five a side 
once a week though.  
Pharmacist: So you’ve always been active? 
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P: Have to, have to do it.  
Pharmacist: So they tell me. That’s why I’ve joined the gym. Well, lovely chatting to 
you Mr [name] (OBS-006) 
These exchanges provided opportunity for brief, light-hearted, informal interaction, but were 
rarely used to build rapport as the basis for a more meaningful consultation: 
Pharmacist: One aspect of medicines, one that gets overlooked is healthy lifestyle. 
What about exercise, does not have to be 100m sprint. Could be swimming, do you 
like that?  
Person: [Older woman who has had knee replacement]. No. I stay active. I get out 
every day to go to a café. I have got one of those pedal things, on top of the heater in 
the garage. 
Pharmacist: Good for you.  
They joke about exercise equipment having an effect on their health from the garage. 
(OBS-012). 
Pharmacists were especially concerned to avoid negative reactions, assuming people would 
not want to talk about ‘difficult’ topics like alcohol:  
It’s a subject that people don’t want to talk [about]…you become expert in other 
things that people are…happy to discuss (INV-I-PH2). 
Observed MURs offered little opportunity to explore health-related behaviours from the 
patient’s viewpoint. The interactions confirmed the existing role of pharmacists as providing 
medicine safety advice, rather than supporting healthy-living choices.  Patients often spoke in 
terms of providing information to the pharmacist rather than negotiating information: 
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I was just in a way answering his questions because he was asking me about things 
wasn’t he? (INV-002 PA).  
Our observations of MURs echoed the findings of Latif et al (2018). These were polite 
encounters designed not to take up too much ‘customer’ or pharmacist time.  MURs were 
further constrained by a business orientated organisational culture and the busy community 
pharmacy environment.  Pharmacists and patients exchanged mainstream, ‘common-sense’ 
ideas about healthy-living, in ways that did not resemble a discussion likely to be helpful as a 
behavioural intervention. 
 
An example demonstrates the challenges faced by community pharmacists, in offering 
‘pastoral care’.  A woman prescribed medication for an underactive thyroid and anxiety, was 
offered a MUR: 
Pharmacist asks, ‘do you smoke’? The woman says ‘yeah’. Pharmacist then asks 
‘have you ever considered quitting?’ She says, ‘No, I’m not ready’ and explains that it 
helps with her anxiety. When she is panicky she goes outside and has a cigarette and 
it helps her feel better.  Pharmacist then says that if you are ever ready you can come 
in here as we do smoking cessation and asks her whether she has tried e-cigarettes. 
The woman talks about how she did once but that she doesn’t get much from them.  
Pharmacist then asks her how many she smokes a day. The woman says ‘15-20’. 
Pharmacist then says, ‘it’s one of the things you can do for your health, but you have 
to be ready to quit.’ (OBS 006). 
The woman went on to raise concerns about her weight. The pharmacist referred to 
information on the internet and suggested she see her doctor:  
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The woman says she was also wondering if she could see a dietician to help her lose 
weight…it is getting her down that she has ‘piled on the weight’. Pharmacist says, 
‘yes you can go to the doctor and get a referral but you can start with little changes.  
They make a difference’. The woman says that she is eating all the ‘bad things, like 
chocolate’ because she feels down, but she knows that does not help. Pharmacist then 
says, ‘do you use the internet?’ The woman nods, and pharmacist says that there is 
lots on there about what is in your food and ‘you know the foods to avoid’. The 
woman explains that she wanted to do Slimming World but that she has no family up 
here and she’s got two kids. Pharmacist offers the woman the scales in the 
appointment room as an option. She says you can always come in here once a week 
and weigh yourself. We can take readings too if you like when you are ready…She 
says that if you start taking the [thyroid medication] you won’t lose weight because 
‘you’ve already piled it on, so you have to make an effort to lose the weight as well’ 
(OBS 006).    
While trying to be helpful, the pharmacist largely left the woman to her own devices, having 
to be ‘ready to quit’ smoking and needing to ‘make an effort’ to lose weight.  Her anxiety 
was not addressed. 
 
A second example demonstrates how information, rather than advice, was seen as sufficient 
to facilitate behavioural change.  Most of the pharmacies we observed ran health promotion 
campaigns in response to local authority or other demands.  Little proactive follow-up, 
however, was offered.  One pharmacist who had managed a HLP for eight years said that 
pharmacies should be a ‘platform for wellbeing’ and a ‘health hub’, where people were able 
to browse information, while waiting for their medicines (OBS-001).   In her own practice, 
this consisted of many leaflets and posters from numerous charities, in addition to alcohol 
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industry sources, which is not without controversy (see McCambridge, 2014).  She said 
providing information in leaflets might ‘help people change’.  A view expressed by many 
community pharmacists, who more generally, were comfortable with offering information or 
product-led services (such as nicotine replacement and smoking cessation) rather than a more 




Martin and Waring (2018) note that the literature on governmentality over-emphasises the 
control of patients and neglects how ‘experts’ are also disciplined through these governing 
rationalities (see also Miller and Rose, 2008). The ‘pastoral’ metaphor, conjuring the idea of 
flocks to be managed, can be extended to pharmacists as well as patients. In agreeing to act as 
conduits of disciplinary power, community pharmacists present opportunities for State 
regulation and intervention, thereby becoming subjects of disciplinary power themselves 
(Jones, 2018). ‘Pastoral power’ and ‘the pharmacy gaze’ are embedded in a broader 
governmentality which operates as a form of power that exploits professional ambiguity to 
‘manage’ the subjectivities of community pharmacists working in an increasingly corporate 
retail environment. The direction from pharmacy leaders in response to economically and 
ideologically driven demands suggests the profession can increase its patient-facing role with 
minimal additional training, while continuing with its existing workload. This, while an 
understandable response to continuing threats to professional standing, struggles to reconcile 
pharmacy as a potential resource with clarification of what constitutes effective ‘pharmacy 




The public health activities observed largely comprised the instrumental provision of 
remunerated services that involved asking closed questions; offering ‘common-sense’ 
information or advice; and displaying and distributing leaflets. Healthy living discussions 
rarely involved any substantial exploration of people’s medicines and health; or more 
generally, about how they lived their lives (see also Morton et al. 2015). The latest quality 
standard for promoting health and well-being in community pharmacies posits that informal 
conversations ‘may encourage people to ask more questions, consider how they feel or how 
their behaviours may be affecting their health’ (NICE, 2020). Interactions observed were 
friendly and transactional but rarely patient-centred or appreciative of an understanding of 
how behavioural change is aired or socially negotiated.  Pharmacists continued to prioritise 
product safety (medicines) and customer satisfaction (business).  The ‘pharmacist gaze’ 
during the MUR was on the list of medicines taken by the patient; checking that these were 
being taken as prescribed; and on the form to be completed. Issues raised by patients were not 
explored and the pharmacist gaze was averted from particularly uncomfortable areas like 
alcohol use.  
 
Pharmacists frequently confused offering advice with a proactive and tailored engagement 
with the complex nuances of patient narratives. So, while accessible, they struggled to 
encourage people to act as active reflexive agents, making choices, supported by expert 
professional advice (Lupton, 2012).  The provision (rather than negotiation) of information 
was seen as sufficient in encouraging patients to take responsibility for their own health. 
Consequently, pharmacists failed to begin to address the broader social determinants of 
health, consistent with the profession’s public health aspirations (see Jesson and Bissell, 
2006).  Converting generic advice, meaningfully related to the broadening public health 
agenda, with the exercise of specialised knowledge, rarely occurred.   Interventions for 
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alcohol, and weight management that go beyond information and the offer of facilities for 
weighing, are particularly difficult to implement when compared to smoking cessation where 
an off-the-shelf product is available.   They require person-centred skills, which according to 
professional and policy documents, pharmacists possess.  Our empirical material suggests 
dissonance between an assumed professional ideal and its practical application. 
 
Attempts to offer advice were further undermined by confusion about the purpose of the 
interactions we observed.  Pharmacists found it difficult to offer clarity on the intent of 
healthy living advice within the context of a medicines-use review and lacked confidence 
when discussing areas they considered sensitive.  Nor did they wish to upset their 
‘customers’. This uncertainty led patients to disregard information, particularly when they 
could not understand its relevance. Some people waiting for their medicines were happy to 
‘chat’, but few accorded it a great deal of significance because this was not invited.  This 
compared unfavourably to how patients viewed contact with GPs. Patient narratives do 
suggest a respect for the pharmacist’s role and expertise (also see Hibbert et al., 2002), but 
this is conditional.  Little understanding of community pharmacy’s aspirations to offer an 
extended role was evident.   
 
Closed pharmacist-led transactions, therefore, curtailed opportunities for ‘pastoral care’ 
(Waring et al., 2016). The aspirational evolution from an initial narrow, product-centred 
model to a more patient-centred model remained incomplete.  Consequently, pharmacists 
fulfilled a rhetorical role in the governmentality of healthy living, and this seemed more 
effective in managing pharmacy practice than the actions of patients/customers.  At 
organisational levels, the ‘pharmacy gaze’ was on financial targets. Dispensing and achieving 
contracted service targets left little time for pharmacists to actually spend with patients. MUR 
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recruitment targets focus on those most likely to agree so excluding people with more 
complex needs and from medically underserved groups (Latif et al., 2019). Pharmacies were 
also affected by GP workforce shortages in primary care and, rather than a professional ‘turf-
war’ with GPs, extended services were perceived as part of a bid for financial and 
professional survival and hope of a vaguely more patient-oriented future.  
 
The requirement for community pharmacists to exercise expert knowledge, on issues about 
which they have little substantial previous engagement or formal education, while juggling 
competing tasks, within a mercantile environment, creates considerable challenges when 
establishing an effective and collaborative relationship with patients.  Visible and audited 
performance seemingly assumed greater importance than meaningfully helping people. 
Consequently, an extended role risks exposing a lack of ‘expert’ knowledge rather than 
enhancing professional standing; reinforcing a confusion between public health expertise and 
‘common sense’ injunctions; and creating the potential for community pharmacists to seem 
culpable if customer/patient self-care is not realised.   By offering superficial sites of practice, 
a more obvious governmentality (and the associated fragility of underfunded primary care 
and public health services) is concealed and protected (see Petersen, 1997). The State’s 
commitment to health-for-all, however, is visibly maintained.  
 
Filling the evidence gap on health outcomes could help challenge professional ambiguity in 
community pharmacy if evaluation is informed by theory grounded in the dynamics of actual 
pharmacy and public health practice (Madden et al., 2020). Poorly evidenced top-down 
initiatives continue to be introduced with little involvement of those who deliver and receive 
them on whether the policy visions proposed for extending pharmacy are practical, desirable 
or meaningful to them.  Pharmacies observed paid little proactive attention to population 
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health intelligence or local community assets (Royal Pharmaceutical Society, 2014), but were 
expected to respond promptly and politely to whatever came in through the door. There was 
no evidence of a public health gaze on the wider social and economic determinants of health. 
This was further outside the pharmacy gaze than a limited version of ‘lifestyle medicine’ 
focused on getting people to ‘take responsibility’ for their health (Sayburn, 2018).To 
successfully utilise the potential future presented by a public health role, community 
pharmacists could usefully explore how best to support an individual to manage the context, 
in which they have to realise healthy lifestyles, where inequality creates differential health 
outcomes (Popay et al., 2010).  Bridging the gap between pharmaceutical and social 
prescribing practices (Bickerdike et al., 2017), for example, could ensure meaningful and 
grounded advice that improved the potential for healthy outcomes. This utilises the public 
heath space offered and affords some protection against the subverting and eroding 
challenges posed by ‘McDonaldization’, in which standardisation,  particularly the need to 
offer short-term, institutionally-specific returns rather than long-term, cumulative effect, 
constrains the exercise of professional discretion.  
 
The difficulties community pharmacists face in negotiating the more individualistic 
tendencies in healthcare offer little substantial protection against becoming passive vessels 
for the enactment of consumerist healthcare policies. Discursive practices are not, however, 
merely textual or abstract, but realised through social practices.  Power (and governmentality) 
is pervasive but negotiable (Martin and Waring, 2018).  Questioning how community 
pharmacy currently imagines public health may offer a more appropriate basis on which to 
develop more sustainable claims to professional status.  This implies a more critical regard 
for how the ‘art of living’ (Rose, 2009) becomes defined through the process of social 
negotiation (Marsland and Prince, 2012).  Such an approach forms the basis on which 
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community pharmacy can challenge existing practices and offer alternative futures.  In doing 
so, it can move beyond the technical act of prescribing medicines, to one more consistent 
with broader definitions of medicine as a ‘social good’ (see Harding and Taylor, 1997). 
Engaging with normative assumptions and understanding how patients conceptualise healthy 
living, represent valuable starting points.  
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